Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T16:15:44.563Z.
Calculation as of: 2026-10-06T16:15:44.563Z.
Quote observation: 2026-10-06T16:01:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c64da899843448fde498cf5e629ee28b7cf55c7878198a0aebccb75d14602d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aspire Biopharma Holdings, Inc.
Market Cap
$1.04M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$869976.00
EV/Sales Ratio
N/A
TTM Avg
48327.79x
3Y Avg
43699.06x
5Y Avg
43699.06x
Market Cap
$869274.00
EV/Sales Ratio
N/A
TTM Avg
4140.29x
3Y Avg
121199.79x
5Y Avg
70235.45x
Market Cap
$859931.00
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$845829.00
EV/Sales Ratio
N/A
TTM Avg
78.84x
3Y Avg
47.25x
5Y Avg
902.93x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.04M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | 0.33x | 0.51x | 0.45x | 1.23x |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $869976.00 | N/A | 48327.79x | 43699.06x | 43699.06x |
| Sunshine Biopharma, Inc. (SBFM)vs › | $869274.00 | N/A | 4140.29x | 121199.79x | 70235.45x |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | N/A | 78.84x | 47.25x | 902.93x |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.24M | 22.69x | 279.56x | 279.56x | 279.56x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-08-13 | 181.49x |
| 2026-08-12 | 182.35x |
| 2026-08-11 | 203.12x |
| 2026-08-10 | 210.91x |
| 2026-08-07 | 208.31x |
| 2026-08-06 | 179.33x |
| 2026-08-05 | 187.98x |
| 2026-08-04 | 178.46x |
| 2026-08-03 | 186.68x |
| 2026-07-31 | 155.96x |
| 2026-07-30 | 164.62x |
| 2026-07-29 | 116.59x |
| 2026-07-28 | 187.55x |
| 2026-07-27 | 175.43x |
| 2026-07-24 | 187.98x |
| 2026-07-23 | 185.81x |
| 2026-07-22 | 209.61x |
| 2026-07-21 | 200.09x |
| 2026-07-20 | 158.56x |
| 2026-07-17 | 143.85x |
| 2026-07-16 | 145.58x |
| 2026-07-15 | 135.20x |
| 2026-07-14 | 134.76x |
| 2026-07-13 | 132.17x |
| 2026-07-10 | 133.90x |
| 2026-07-09 | 136.49x |
| 2026-07-08 | 123.95x |
| 2026-07-07 | 116.59x |
| 2026-07-06 | 128.27x |
| 2026-07-02 | 142.55x |
| 2026-07-01 | 127.41x |
| 2026-06-30 | 104.91x |
| 2026-06-29 | 139.52x |
| 2026-06-26 | 133.47x |
| 2026-06-25 | 153.37x |
| 2026-06-24 | 156.83x |
| 2026-06-23 | 140.82x |
| 2026-06-22 | 146.01x |
| 2026-06-18 | 158.56x |
| 2026-06-17 | 149.04x |
| 2026-06-16 | 141.69x |
| 2026-06-15 | 118.32x |
| 2026-06-12 | 88.47x |
| 2026-06-11 | 133.47x |
| 2026-06-10 | 116.59x |
| 2026-06-09 | 132.17x |
| 2026-06-08 | 161.59x |
| 2026-06-05 | 104.91x |
| 2026-06-04 | 135.63x |
| 2026-06-03 | 126.54x |
| 2026-06-02 | 134.33x |
| 2026-06-01 | 131.74x |
| 2026-05-29 | 111.40x |
| 2026-05-28 | 113.13x |
| 2026-05-27 | 75.93x |
| 2026-05-26 | 93.23x |
| 2026-05-22 | 107.94x |
| 2026-05-21 | 115.73x |
| 2026-05-20 | 134.76x |
| 2026-05-19 | 126.11x |
| 2026-05-18 | 162.89x |
| 2026-05-15 | 2024.84x |
| 2026-05-14 | 2087.51x |
| 2026-05-13 | 1950.12x |
| 2026-05-12 | 1918.78x |
| 2026-05-11 | 2003.15x |
| 2026-05-08 | 2010.38x |
| 2026-05-07 | 1793.44x |
| 2026-05-06 | 2017.61x |
| 2026-05-05 | 2118.85x |
| 2026-05-04 | 2186.34x |
| 2026-05-01 | 2208.03x |
| 2026-04-30 | 2273.11x |
| 2026-04-29 | 2437.02x |
| 2026-04-28 | 2181.52x |
| 2026-04-27 | 2444.26x |
| 2026-04-24 | 2155.00x |
| 2026-04-23 | 2227.32x |
| 2026-04-22 | 2280.35x |
| 2026-04-21 | 2094.74x |
| 2026-04-20 | 2567.19x |
| 2026-04-17 | 2622.63x |
| 2026-04-16 | 2841.98x |
| 2026-04-15 | 4613.65x |
| 2026-04-14 | 9277.86x |
| 2026-04-13 | 8916.29x |
| 2026-04-10 | 8337.79x |
| 2026-04-09 | 9350.17x |
| 2026-04-08 | 9277.86x |
| 2026-04-07 | 8265.47x |
| 2026-04-06 | 8843.98x |
| 2026-04-02 | 8048.53x |
| 2026-04-01 | 7976.22x |
| 2026-03-31 | 8120.85x |
| 2026-03-30 | 21619.64x |
| 2026-03-27 | 20917.96x |
| 2026-03-26 | 20854.17x |
| 2026-03-25 | 25064.26x |
| 2026-03-24 | 18806.53x |
| 2026-03-23 | 20075.94x |
| 2026-03-20 | 17179.91x |
| 2026-03-19 | 16018.94x |
| 2026-03-18 | 16822.69x |
| 2026-03-17 | 20190.76x |
| 2026-03-16 | 22098.06x |
| 2026-03-13 | 23533.32x |
| 2026-03-12 | 25064.26x |
| 2026-03-11 | 27360.67x |
| 2026-03-10 | 26786.57x |
| 2026-03-09 | 26403.83x |
| 2026-03-06 | 25638.36x |
| 2026-03-05 | 28508.88x |
| 2026-03-04 | 28700.24x |
| 2026-03-03 | 31570.76x |
| 2026-03-02 | 31188.02x |
| 2026-02-27 | 30039.82x |
| 2026-02-26 | 31188.02x |
| 2026-02-25 | 30805.29x |
| 2026-02-24 | 29848.45x |
| 2026-02-23 | 28317.51x |
| 2026-02-20 | 30805.29x |
| 2026-02-19 | 31570.76x |
| 2026-02-18 | 33101.70x |
| 2026-02-17 | 33867.17x |
| 2026-02-13 | 30805.29x |
| 2026-02-12 | 28508.88x |
| 2026-02-11 | 29274.35x |
| 2026-02-10 | 30422.55x |
| 2026-02-09 | 30996.66x |
| 2026-02-06 | 31379.39x |
| 2026-02-05 | 28700.24x |
| 2026-02-04 | 33101.70x |
| 2026-02-03 | 34632.64x |
| 2026-02-02 | 35972.22x |
| 2026-01-30 | 44201.03x |
| 2026-01-29 | 31379.39x |
| 2026-01-28 | 33867.17x |
| 2026-01-27 | 34249.91x |
| 2026-01-26 | 37120.42x |
| 2026-01-23 | 39608.20x |
| 2026-01-22 | 38077.26x |
| 2026-01-21 | 39990.94x |
| 2026-01-20 | 41904.61x |
| 2026-01-16 | 45731.97x |
| 2026-01-15 | 43244.19x |
| 2026-01-14 | 48602.48x |
| 2026-01-13 | 64677.37x |
| 2026-01-12 | 76159.43x |
| 2026-01-09 | 83048.67x |
| 2026-01-08 | 82283.20x |
| 2026-01-07 | 99889.03x |
| 2026-01-06 | 83814.14x |
| 2026-01-05 | 95296.20x |
| 2026-01-02 | 108309.21x |
| 2025-12-31 | 104481.85x |
| 2025-12-30 | 112136.56x |
| 2025-12-29 | 86110.55x |
| 2025-12-26 | 86110.55x |
| 2025-12-24 | 77690.37x |
| 2025-12-23 | 76159.43x |
| 2025-12-22 | 77690.37x |
| 2025-12-19 | 78455.84x |
| 2025-12-18 | 79986.79x |
| 2025-12-17 | 76924.90x |
| 2025-12-16 | 83048.67x |
| 2025-12-15 | 85345.08x |
| 2025-12-12 | 76159.43x |
| 2025-12-11 | 83814.14x |
| 2025-12-10 | 68504.72x |
| 2025-12-09 | 73097.55x |
| 2025-12-08 | 73097.55x |
| 2025-12-05 | 73863.02x |
| 2025-12-04 | 73863.02x |
| 2025-12-03 | 71566.61x |
| 2025-12-02 | 79986.79x |
| 2025-12-01 | 79221.32x |
| 2025-11-28 | 84579.61x |
| 2025-11-26 | 83048.67x |
| 2025-11-25 | 80752.26x |
| 2025-11-24 | 79986.79x |
| 2025-11-21 | 77690.37x |
| 2025-11-20 | 78455.84x |
| 2025-11-19 | 79221.32x |
| 2025-11-18 | 84579.61x |
| 2025-11-17 | 73097.55x |
